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Abstract 
Primitive IMT represent 8-10% of all 
primary tumors of the spinal cord. Only 2-
4% of all CNS tumors in adults are IMT. 
Adult astrocytomas are 25-35% of total 
IMT (1). 
We prospectively analyzed clinical, 
imaging and pathological data from all 
consecutive patients operated for 
intramedullary tumors in our department 
(Neurosurgery I Clinic, Ward II) between 
January 2003 and August 2009 (80 months). 
All surgical interventions were performed 
by the same surgical team. We emphasized 
the technical difficulties raised by ablation 
of IMT depending on the type of the tumor 
and postoperative neurological outcome. 
Key words: intramedullary 
astrocytomas, surgery, postoperative 
neurological outcome. 
Abreviations: CNS – central nervous 
system, intramedullary tumors – IMT, 
spinal cord - SC. 
General data 
Primitive IMT represent 8-10% of all 
primary tumors of the spinal cord. Only 2-
4% of all CNS tumors in adults are IMT. 
SC tumors are much less common than 
intracranial tumors with an overall 
prevalence of approximately an 
intramedullary tumor for four intracranial 
tumors, with variations depending on the 
type of tumor. For example, the location 
intracranial/spinal for astrocytomas is 
approximately 10/1, while the same ratio for 
ependymomas varies from 3/1 to 20/1 
depending on the histological type of 
ependymoma. In particular, mixo-papillary 
ependymomas are found more frequently 
in the SC (1). 
Material and methods 
Patients enrolled in the study were 
hospitalized and operated in the period 
2003-2009 in Neurosurgery I Clinic, Ward 
II, "Bagdasar-Arseni" Clinical Emergency 
Hospital for IMT in various locations. 59 
patients were included in the study, age 
between 15 and 70 years,  40% female sex 
ratio = 1.5. 62 surgeries were performed. 
All patients were operated on by the same 
surgical team, same main operator. 
Result distribution 
In the series we have studied the 
distribution by frequency of pathological 
diagnoses found is the following: 
- first place is occupied by 
ependymomas, which account for about 
half of all pathological types  - 29 cases 
(46.77%) 
-  on the second place are astrocytomas 
15 cases ( 24.19%) 
-  third place  hemangioblastomas  5 
cases ( 8.06%) 
- the fourth place two lipomas and a 
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fibrolipoma summing 3 cases  (4.83%) 
- on the fifth place are  cavernomas, 
meduloblastomas, gangliogliomas, 
schwanomas by 2 cases = 3.22% each, 
summimg  8 cases = 12.88% 
- the sixth  place epidermoid cyst and a  
metastasis 1 case = 1.61% each, totaling 2 
cases = 3.22% 
Note that the first three histological 
types, ependymomas, astrocytomas, 
hemangioblastomas adds up to approx. 80% 
of all IMT in adults. All other seven 
histological types account for the remaining 
20% 
Analysis of tumor histology for 
astrocytomas revealed predominant WHO 
grades I and II - 11 cases, compared with 
grades III and IV - 4 cases. The most 
common subtype was fibrillary 
astrocytoma, 6 cases. 
 
Figure 1 Pathological types of astrocytomas 
 
  
A                                  B 
Figure 2  Thoracic pilocitic astrocytoma, 
preoperative 
A – T1 image, dye examination 
B – T2 image 
 
Preoperative diagnosis was made by 
MRI in all cases, native examination and 
T1-dye examination. 
Location: 
- 2 cervical astrocytomas - 13.33% (of 
total astrocytoma localization) 
- 1 cervico-thoracic astrocytoma - 6.66% 
- 12 thoracic astrocytomas - 80.00% 
Most frequent location is the thoracic 
spine region - 80%. Astrocytomas occupied 
between 2 and 4 vertebral segments, with 
an average of 2.86 vertebral levels. 
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Figure 3   Astrocytomas location relative to the vertebral 
segments (abscissa - C1 to L1 vertebral segments, the 
ordered number of cases each vertebral level) 
Surgery 
Anesthesia, patient positioning and 
wound opening, laminoplasty or 
laminectomy, opening and suspension of 
dura mater and arachnoid and wound 
closure are similar to surgery for any IMT.  
Myelotomy is more difficult for 
astrocytomas compared to the same 
maneuver for ependymomas (2). These 
problems are caused by the fact that 
astrocytomas are not developed in the 
midline, are IMT with asymmetric 
development. In addition the SC may be 
"distorted", anatomical landmarks being no 
longer valid. Whenever possible, it is 
recommended myelotomy in the posterior 
midline. Finding solutions for posterior 
midline are coagulation and cutting 
tortuous veins usually found on the 
posterior surface  of the SC and subsequent 
search for the posterior midline in the area 
where SC have anatomic appearance above 
and below the area of astrocytoma 
development.  
Another solution is mielotomy in the 
dorsal root entry zone (DREZ) where the 
extension of the tumor is greater and 
neurological deficits are higher. As ultimate 
solution is used the myelotomy in the area 
where astrocytoma is closest to the 
posterior surface of the SC, the aim being 
to harm as little as possible the medullary 
tissue. 
Astrocytoma biopsy to determine the 
degree of malignancy is the next step, 
which may be decisive for the further 
conduct of the surgeon. If biopsy results 
revealed low-grade astrocytoma, we always 
tempted total or almost total ablation of 
astrocytoma. Although pathological results 
showed high-grade astrocytoma we was 
looking for an eventual cleavage plane and 
tried subtotal or nearly  total ablation of 
astrocytoma. The same attitude was 
adopted in situations where polar cysts were 
encountered. We started to search for the 
cleavage plane between the tumor and 
normal medullary tissue, near the cysts. 
Always be dissected with extreme caution, 
lateral sides of astrocytomas, which may 
come in contact with cortico-spinal tracts 
and the front of astrocytomas, that 
sometimes "stuck" anterior spinal artery. 
Cortico-spinal tracts damage and/or 
anterior spinal artery lesions causes 
significant postoperative neurological 
deficits, most often irreversible (3, 4, 5). 
  Tumor ablation technique used was 
intratumoral partial ablation, emphasizing 
the "step by step" plan and finding the 
cleavage plane fragment by fragment. The 
internal pressure relief stitch was used in 2 
cases when the astrocytoma extended for 4 
vertebral levels. Whatever type of tumor 
ablation, hemostasis was achieved by mild 
pressure, washing the wound with cold 
saline and wallpapering outstanding 
intramedullary cavity with Surgicel. 
 Type of tumor ablation 
Total ablation was possible in 2 cases 
(13.33%), a T2-T4 thoracic pilocytic 
astrocytoma and a fibrillary astrocytoma 
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T9-T10, situations in which was possible to 
found a cleavage plane. 
Nearly total ablation was performed in 
one case (6.66%), a pilocytic astrocytoma 
T11- L1. 
The most common was subtotal ablation 
in 10 cases (66.66%) being imposed by the 
infiltrative nature of tumor formation 
(glioblastoma one  case, 3 cases of anaplastic 
astrocytoma, diffuse infiltrative fibrillary 
astrocytoma grade II / III WHO  one case) 
and unable to find a plane of cleavage 
between the IMT and normal medullary 
tissue in the other cases (2). 
Biopsy was chosen as a temporary 
solution in two cases (13.33%), in which 
intra-operative cardiovascular disorders 
were recorded, the primary surgeon’s 
decision was to minimize the duration of 
the intervention. Pathological results were 
pilocytic astrocytoma in one case and 
fibrillary astrocytoma in the other. A second 
intervention was scheduled within the first 
14 days postoperatively performing the 
almost total ablation in the first case and the 
subtotal ablation in the second case. 
 
  
Figure 4   T1, sagital; T2, sagital 
Pilocitic astrocytoma 
 
Figure 6   Types of tumor ablation 
 
Intraoperative complications 
Intraoperative bleeding was not 
significant except for one case; the thoracic 
astrocytoma was extended on 4 levels. In 
the two cases described above, in which 
biopsy was performed only at the first 
surgery, complications are caused by 
cardiovascular pathology that patients 
already had and were not related to  
location or type of excision of IMT. 
Postoperative complications 
  No significant postoperative 
complications were recorded. 
 
  
A                                    B 
Figure 5  Thoracic pilocitic astrocytoma, six months 
postoperative 
A -  T1 dye examination, image  
B – T2 image 
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Discussion 
Postoperative neurological evolution  
There were no significant neurologic 
deficits. Additional motor deficit was 
averaging 1.2 points on ASIA scale and 
sensitivity disorders, except deep sensibility 
disorders, not widened. Favorable evolution 
from both surgical and neurological point 
of view is related to the location of IMT 
and the type of ablation. The tumors in low 
thoracic spinal cord had the lower critical 
risk (in our series there were no 
astrocytomas located above C4). The type 
of tumor resection  is also extremely 
important: there were only 2 cases with 
total resection and 2 cases with subtotal 
resected tumors. 
 In other words, if the IMT location is 
"high" and/or tumor ablation attempt more 
radical (total or almost total), the vital and 
neurological risks and complications are 
higher (6, 7, 8, 9).  
Postoperatively there has been no 
significant neurological worsening, no 
death registered. 
Explanations are: 
- Type of ablation that was only in 2 
cases total and in one case quasi total 
determined by the presence of cleavage 
plane; 
- Predominantly astrocytomas location 
in thoracic levels, 12 cases, only 2 locations 
cervical and 1 cervico-thoracic junction 1; 
- Surgery less "aggressive" if the 
pathological results were high-grade 
astrocytomas. 
  Type of tumor ablation should be 
adapted to histological subtype of 
astrocytoma and especially must take into 
account the existence or absence of a 
cleavage plane (8, 9). Brotchi (2) in an 
article published in 1997 emphasizes that 
any surgical attitude addopted, if the 
astrocytoma is grade III or  IV, long-term 
results are similar. In these cases  the 
surgeon's duty is  to obtain a correct 
pathological result, to achieve 
decompression of the SC without affecting 
medullary tissue, without postoperative 
neurological deterioration. 
Adjuvant treatment 
Radiation 
Radiation therapy has no indication for 
low-grade astrocytomas. All authors (2, 3, 4, 
5, 6)  agree that in pilocytic astrocytoma 
WHO grade I postoperative radiotherapy 
should not be done, just followed up the 
evolution by  clinical and imaging 
surveillance. In these cases the neurological 
evolution, the risk of relapse and duration 
of postoperative survival are directly related 
to the type of tumor ablation, total or that 
sometimes occur after radiation: myelitis 
postirradiation and bone-marrow 
suppression. 
For high-grade gliomas, WHO grade III 
and IV was made postoperative 
radiotherapy, fractionated doses of 50-54 
Gy in 24 sessions.  
For grade II gliomas WHO histological 
with features of malignancy and recurrent 
gliomas grade II radiotherapy was made 
with doses of 40-46 Gy, fractionated in 20 
sessions (10). 
Postoperative radiotherapy was done in 
patients with WHO grade III anaplastic 
astrocytomas (3 cases),  glioblastoma WHO 
grade IV (1 case) and in WHO grade II 
astrocytomas with  anaplastic histological 
elements (1 case) in which we could not 
perform complete ablation. 
Chemotherapy 
It was recommended as adjuvant therapy 
in the pediatric population because of 
disastrous side effects that radiation has on 
children. For adults was indicated in cases 
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where astrocytomas are WHO grade III and 
IV, IMT resection was not complete, did 
not respond to radiotherapy and tumor 
recurrences were recorded or "tumoral 
growth" continues.  Etoposide was used 
initially, then Temozolamide. 
Temozolamide  administered in doses of 
150-200 mg./m2/day  for 5 days a week for 
4 weeks = a cycle (11). 
In the present series we did not have 
patients with postoperative chemotherapy.                               
Conclusions 
- Astrocytomas grade I could be 
completely or partially ablated. Total or 
almost total ablation is due to the cleavage 
plane between IMT and normal medullary 
tissue. In low-grade astrocytomas, where 
there plane cleavage is present, total or 
almost total ablation is the goal. 
- Astrocytomas grade III and IV and part 
of grade II astrocytomas (with anaplastic 
cells elements) were subtotally ablated 
because of their infiltrative nature. 
- There were no major intraoperative 
complications, postoperative immediately 
and/or delayed. 
- All cases of grade III and IV 
astrocytomas have clear indication for 
postoperative radiotherapy. 
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